R&D | May 14, 2026
Merck to showcase 100+ oncology studies at 2026 ASCO meeting
Highlighting KEYTRUDA & expanding cancer pipeline
Highlighting KEYTRUDA & expanding cancer pipeline
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
Expands manufacturing push & locks in major growth deals
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
